Editorial - Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment.

Nastri, B M; Zannella, C; Folliero, V; Rinaldi, L; Restivo, L; Stelitano, D; Sperlongano, R; Adinolfi, L E; Franci, G

Nastri, B M; Zannella, C; Folliero, V; Rinaldi, L; Restivo, L; Stelitano, D; Sperlongano, R; Adinolfi, L E; Franci, G.

Nastri BM; Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy. gfranci@unisa.it.

Eur Rev Med Pharmacol Sci ; 24(22): 11982-11984, 2020 11.

Article in English | MEDLINE | ID: covidwho-962035

Subject(s)

Antiretroviral Therapy, Highly Active; COVID-19 Drug Treatment; Coronavirus Protease Inhibitors/therapeutic use; HIV Infections/drug therapy; Reverse Transcriptase Inhibitors/therapeutic use; SARS-CoV-2/metabolism; Coronavirus 3C Proteases/antagonists & inhibitors; Coronavirus 3C Proteases/metabolism; Coronavirus RNA-Dependent RNA Polymerase/antagonists & inhibitors; Coronavirus RNA-Dependent RNA Polymerase/metabolism; Drug Repositioning; Humans; Integrase Inhibitors/therapeutic use; Severity of Illness Index; Viral Protease Inhibitors/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Reverse Transcriptase Inhibitors / Antiretroviral Therapy, Highly Active / Coronavirus Protease Inhibitors / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2020 Document Type: Article Affiliation country: Eurrev_202011_23861

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google